Successful treatment of idiopathic angioedema with ecallantide

J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):297-8. doi: 10.1016/j.jaip.2013.03.007. Epub 2013 Apr 29.

Authors

Alalia Berry¹, Rafael Firszt²

Affiliations

¹ Department of Medicine, Division of Allergy and Immunology, University of Utah, Salt Lake City, Utah.
² Department of Pediatrics, Division of Allergy and Immunology, University of Utah, Salt Lake City, Utah. Electronic address: rafael.firszt@hsc.utah.edu.

PMID: 24565489
DOI: 10.1016/j.jaip.2013.03.007

No abstract available

Publication types

Case Reports

MeSH terms

Abdominal Pain / diagnosis
Abdominal Pain / drug therapy
Abdominal Pain / etiology
Adolescent
Angioedema / diagnosis*
Angioedema / drug therapy*
Angioedema / etiology
Bradykinin / antagonists & inhibitors
Bradykinin / biosynthesis
Complement C1 Inhibitor Protein / biosynthesis
Complement C1 Inhibitor Protein / physiology
Face*
Female
Humans
Peptides / administration & dosage*
Peptides / therapeutic use
Radiography, Thoracic
Tomography, X-Ray Computed

Substances

Complement C1 Inhibitor Protein
Peptides
ecallantide
Bradykinin